Arcturus Therapeutics Holdings Inc (ARCT) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Arcturus Therapeutics Holdings Inc has achieved a revenue compound annual growth rate (CAGR) of 181.2%, while earnings have grown at 10.6% CAGR.
Historical revenue and profitability trends for Arcturus Therapeutics Holdings Inc
The chart above illustrates Arcturus Therapeutics Holdings Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Arcturus Therapeutics Holdings Inc's business.
How efficiently Arcturus Therapeutics Holdings Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Arcturus Therapeutics Holdings Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Arcturus Therapeutics Holdings Inc to continue focusing on sustainable operations. The consensus analyst rating is 4.7273 based on 11 analysts.
Based on our comprehensive analysis, Arcturus Therapeutics Holdings Inc (ARCT) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Arcturus Therapeutics Holdings Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Arcturus Therapeutics Holdings Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: ARCT Valuation, ARCT Dividend, ARCT Financial Health
Compare: ARCT vs AAPL, ARCT vs MSFT, ARCT vs GOOGL